Table 2.
Association between various total, LDL and HDL cholesterol, triglyceride values and cancer (multivariable logistic regression models)
| Lab value | Proportion among patients with cancer | Proportion among patients without cancer | OR (95% CI) | p value |
|---|---|---|---|---|
| Total cholesterol (mg/dl) | ||||
| < 200 | 43.9 | 40.9 | Reference | |
| 200–250 | 44.8 | 46.9 | 0.93 (0.89–0.97) | < 0.001 |
| > 250 | 11.3 | 12.2 | 0.89 (0.82–0.95) | < 0.001 |
| LDL cholesterol (mg/dl) | ||||
| < 100 | 20.5 | 18.6 | Reference | |
| 100–160 | 63.0 | 64.0 | 0.97 (0.93–1.02) | 0.212 |
| > 160 | 16.6 | 17.4 | 1.02 (0.94–1.09) | 0.688 |
| HDL cholesterol (mg/dl) | ||||
| > 40 | 84.9 | 86.6 | Reference | |
| 31–35 | 8.6 | 8.2 | 1.02 (0.96–1.09) | 0.461 |
| < 35 | 6.5 | 5.3 | 1.22 (1.13–1.31) | < 0.001 |
| Triglyceride (mg/dl) | ||||
| < 150 | 60.6 | 61.0 | Reference | |
| 150–200 | 21.4 | 21.6 | 0.98 (0.94–1.02) | 0.231 |
| > 200 | 18.0 | 17.4 | 0.99 (0.94–1.04) | 0.625 |
*Adjusted for diabetes, obesity and each of the lipid values (i.e. association between triglyceride and cancer was adjusted for LDL, HDL and total cholesterol, diabetes and obesity)